Related references
Note: Only part of the references are listed.Drug-Induced Nephrotoxicity Assessment in 3D Cellular Models
Pengfei Yu et al.
MICROMACHINES (2022)
The Role of mTOR Signaling as a Therapeutic Target in Cancer
Nadezhda V. Popova et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Carvedilol blocks neural regulation of breast cancer progression in vivo and is associated with reduced breast cancer mortality in patients
Ryan D. Gillis et al.
EUROPEAN JOURNAL OF CANCER (2021)
Endoglin in the Spotlight to Treat Cancer
Teresa Gonzalez Munoz et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Resveratrol significantly improves cell survival in comparison to dexrazoxane and carvedilol in a h9c2 model of doxorubicin induced cardiotoxicity
David S. Monahan et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
Resveratrol-Based Nanoformulations as an Emerging Therapeutic Strategy for Cancer
Javad Sharifi-Rad et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2021)
Liposomal Resveratrol and/or Carvedilol Attenuate Doxorubicin-Induced Cardiotoxicity by Modulating Inflammation, Oxidative Stress and S100A1 in Rats
Abeer M. Alanazi et al.
ANTIOXIDANTS (2020)
Phytochemicals in Cancer Treatment: From Preclinical Studies to Clinical Practice
Amit S. Choudhari et al.
FRONTIERS IN PHARMACOLOGY (2020)
NAF-1 Inhibition by Resveratrol Suppresses Cancer Stem Cell-Like Properties and the Invasion of Pancreatic Cancer
Tao Qin et al.
FRONTIERS IN ONCOLOGY (2020)
Resveratrol: Evidence for Its Nephroprotective Effect in Diabetic Nephropathy
Vemana Gowd et al.
ADVANCES IN NUTRITION (2020)
Endoglin Promotes Myofibroblast Differentiation and Extracellular Matrix Production in Diabetic Nephropathy
Tessa Gerrits et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Cardioprotective effect of grape polyphenol extract against doxorubicin induced cardiotoxicity
Shynggys Sergazy et al.
SCIENTIFIC REPORTS (2020)
Resveratrol-Loaded Lipid Nanocarriers Are Internalized By Endocytosis in Yeast
Celia Barbosa et al.
JOURNAL OF NATURAL PRODUCTS (2019)
Resveratrol As A Natural Regulator Of Autophagy For Prevention And Treatment Of Cancer
Yuanyuan Tian et al.
ONCOTARGETS AND THERAPY (2019)
Endoglin as an Adhesion Molecule in Mature and Progenitor Endothelial Cells: A Function Beyond TGF-β
Elisa Rossi et al.
FRONTIERS IN MEDICINE (2019)
Autophagy and doxorubicin resistance in cancer
Chao Chen et al.
ANTI-CANCER DRUGS (2018)
Co-administration of resveratrol with doxorubicin in young mice attenuates detrimental late-occurring cardiovascular changes
Nobutoshi Matsumura et al.
CARDIOVASCULAR RESEARCH (2018)
Resveratrol liposomes and lipid nanocarriers: Comparison of characteristics and inducing browning of white adipocytes
Yujiao Zu et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2018)
Endoplasmic reticulum-retained podocin mutants are massively degraded by the proteasome
Maria-Carmen Serrano-Perez et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
The Cardioprotective Effect of Metformin in Doxorubicin-Induced Cardiotoxicity: The Role of Autophagy
Rita Zilinyi et al.
MOLECULES (2018)
Targeting oncogenic transcription factors by polyphenols: A novel approach for cancer therapy
Chitra Rajagopal et al.
PHARMACOLOGICAL RESEARCH (2018)
Prevention of Doxorubicin-Induced Renal Toxicity by Theanine in Rats
Katsuhito Nagai et al.
PHARMACOLOGY (2018)
KIM-1 as a Blood-Based Marker for Early Detection of Kidney Cancer: A Prospective Nested Case-Control Study
Ghislaine Scelo et al.
CLINICAL CANCER RESEARCH (2018)
Aspalathin Reverts Doxorubicin-Induced Cardiotoxicity through Increased Autophagy and Decreased Expression of p53/mTOR/p62 Signaling
Rabia Johnson et al.
MOLECULES (2017)
Oxidative Stress and Cellular Response to Doxorubicin: A Common Factor in the Complex Milieu of Anthracycline Cardiotoxicity
Donato Cappetta et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2017)
Resveratrol Regulates Colorectal Cancer Cell Invasion by Modulation of Focal Adhesion Molecules
Constanze Buhrmann et al.
NUTRIENTS (2017)
Prophylactic supplementation of resveratrol is more effective than its therapeutic use against doxorubicin induced cardiotoxicity
Heba Samy Shoukry et al.
PLOS ONE (2017)
UVRAG Deficiency Exacerbates Doxorubicin-Induced Cardiotoxicity
Lin An et al.
SCIENTIFIC REPORTS (2017)
Autophagy is activated to protect against podocyte injury in adriamycin-induced nephropathy
Mixuan Yi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2017)
Kidney Injury Molecule-1 is Elevated in Nephropathy and Mediates Macrophage Activation via the Mapk Signalling Pathway
Lei Tian et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
Resveratrol inhibits ovarian tumor growth in an in vivo mouse model
Lijun Tan et al.
CANCER (2016)
Roles of mTOR complexes in the kidney: implications for renal disease and transplantation
Daniel Fantus et al.
NATURE REVIEWS NEPHROLOGY (2016)
Protective Effects of Carvedilol and Vitamin C against Azithromycin-Induced Cardiotoxicity in Rats via Decreasing ROS, IL1-beta, and TNF-alpha Production and Inhibiting NF-kappa B and Caspase-3 Expression
Nagla A. El-Shitany et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2016)
Mechanisms of Doxorubicin Toxicity in Pancreatic β-Cells
Emma A. Heart et al.
TOXICOLOGICAL SCIENCES (2016)
Protective effect of antioxidant on renal damage caused by Doxorubicin chemotherapy in mice with hepatic cancer
Lei Liu et al.
ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE (2016)
Resveratrol induces autophagy by directly inhibiting mTOR through ATP competition
Dohyun Park et al.
SCIENTIFIC REPORTS (2016)
Possible Protective Effect of Diacerein on Doxorubicin-Induced Nephrotoxicity in Rats
Marwa M. M. Refaie et al.
JOURNAL OF TOXICOLOGY (2016)
Resveratrol supplementation: Where are we now and where should we go?
Marta G. Novelle et al.
AGEING RESEARCH REVIEWS (2015)
18β-Glycyrrhetinic acid exerts protective effects against cyclophosphamide-induced hepatotoxicity: potential role of PPARγ and Nrf2 upregulation
Ayman M. Mahmoud et al.
GENES AND NUTRITION (2015)
18β-Glycyrrhetinic acid exerts protective effects against cyclophosphamide-induced hepatotoxicity: potential role of PPARγ and Nrf2 upregulation
Ayman M. Mahmoud et al.
GENES AND NUTRITION (2015)
The protective effects of ω-3 fatty acids on doxorubicin-induced hepatotoxicity and nephrotoxicity in rats
Feti Tulubas et al.
TOXICOLOGY AND INDUSTRIAL HEALTH (2015)
Protective mechanisms of atorvastatin against doxorubicin-induced hepato-renal toxicity
Mohamed A. El-Moselhy et al.
BIOMEDICINE & PHARMACOTHERAPY (2014)
New Insights into the Mechanism of the DNA/Doxorubicin Interaction
Cristina Perez-Arnaiz et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2014)
Anti-aromatase effect of resveratrol and melatonin on hormonal positive breast cancer cells co-cultured with breast adipose fibroblasts
Suthat Chottanapund et al.
TOXICOLOGY IN VITRO (2014)
Nephrin - a biomarker of early glomerular injury
Yogavijayan Kandasamy et al.
BIOMARKER RESEARCH (2014)
Autophagy Regulation and role in development
Amber N. Hale et al.
AUTOPHAGY (2013)
Synergistic anti-proliferative effect of resveratrol and etoposide on human hepatocellular and colon cancer cell lines
Fatemehsadat Amiri et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2013)
Resveratrol loaded liposomes produced by different techniques
Bojana D. Isailovic et al.
INNOVATIVE FOOD SCIENCE & EMERGING TECHNOLOGIES (2013)
Resveratrol and P-glycoprotein Inhibitors Enhance the Anti-Skin Cancer Effects of Ursolic Acid
Jacob J. Junco et al.
MOLECULAR CANCER RESEARCH (2013)
Effect of dihydrokainate on the capacity of repair of DNA damage and apoptosis induced by doxorubicin
Sabry M. Attia et al.
MUTAGENESIS (2013)
Resveratrol attenuates doxorubicin-induced cellular damage by modulating nitric oxide and apoptosis
Gulperi Oktem et al.
EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY (2012)
Increased risk of hepatocellular carcinoma in patients with diabetes mellitus: A systematic review and meta-analysis of cohort studies
Chenggang Wang et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
The protective effect of aminoguanidine on doxorubicin-induced nephropathy in rats
Osama M. Abo-Salem
JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY (2012)
Is Renal Thrombotic Angiopathy an Emerging Problem in the Treatment of Ovarian Cancer Recurrences?
Maryann Kwa et al.
ONCOLOGIST (2012)
The Redox Imbalance and the Reduction of Contractile Protein Content in Rat Hearts Administered with L-Thyroxine and Doxorubicin
Agnieszka Korga et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2012)
Combining Nitrous Oxide with Carbon Dioxide Decreases the Time to Loss of Consciousness during Euthanasia in Mice - Refinement of Animal Welfare?
Aurelie A. Thomas et al.
PLOS ONE (2012)
Western Blot: Technique, Theory, and Trouble Shooting
Tahrin Mahmood et al.
NORTH AMERICAN JOURNAL OF MEDICAL SCIENCES (2012)
Effect of Coenzyme-Q10 on Doxorubicin-Induced Nephrotoxicity in Rats
Azza A. K. El-Sheikh et al.
ADVANCES IN PHARMACOLOGICAL SCIENCES (2012)
The Beclin 1 network regulates autophagy and apoptosis
R. Kang et al.
CELL DEATH AND DIFFERENTIATION (2011)
Doxorubicin Cardiomyopathy
Kanu Chatterjee et al.
CARDIOLOGY (2010)
Cardioprotection by resveratrol: a novel mechanism via autophagy involving the mTORC2 pathway
Narasimman Gurusamy et al.
CARDIOVASCULAR RESEARCH (2010)
Carvedilol protects against the renal mitochondrial toxicity induced by cisplatin in rats
M. A. Carvalho Rodrigues et al.
MITOCHONDRION (2010)
Protective effect of carvedilol on daunorubicin-induced cardiotoxicity and nephrotoxicity in rats
Wawaimuli Arozal et al.
TOXICOLOGY (2010)
Cardiomyocyte death in doxorubicin-induced cardiotoxicity
Yi-Wei Zhang et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2009)
Protective effects of fullerenol C60(OH)24 against doxorubicin-induced cardiotoxicity and hepatotoxicity in rats with colorectal cancer
Rade Injac et al.
BIOMATERIALS (2009)
Resveratrol treatment protects against doxorubicin-induced cardiotoxicity by alleviating oxidative damage
Elif Tatlidede et al.
FREE RADICAL RESEARCH (2009)
Antioxidant activity of carvedilol in cardiovascular disease
Paresh Dandona et al.
JOURNAL OF HYPERTENSION (2007)
Podocin and MEC-2 bind cholesterol to regulate the activity of associated ion channels
Tobias B. Huber et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Partial Beclin 1 silencing aggravates doxorubicinand Fas-induced apoptosis in HepG2 cells
Fanny Daniel et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2006)
Antioxidant and antiinflammatory effect of carvedilol in mononuclear cells of hypertensive patients
LA Calò et al.
AMERICAN JOURNAL OF MEDICINE (2005)
Carvedilol attenuates ischemia-reperfusion-induced oxidative renal injury in rats
D Singh et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2004)
Anthracyclines: Molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity
G Minotti et al.
PHARMACOLOGICAL REVIEWS (2004)
Caffeic acid phenethyl ester as a protective agent against doxorubicin nephrotoxicity in rats
M Yagmurca et al.
CLINICA CHIMICA ACTA (2004)
Carvedilol prevents doxorubicin-induced free radical release and apoptosis in cardiomyocytes in vitro
P Spallarossa et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2004)
Carvedilol decreases elevated oxidative stress in human failing myocardium
K Nakamura et al.
CIRCULATION (2002)
Resveratrol induces colon tumor cell apoptosis independently of p53 and preceded by epithelial differentiation, mitochondrial proliferation and membrane potential collapse
M Mahyar-Roemer et al.
INTERNATIONAL JOURNAL OF CANCER (2001)
Apoptosis in adriamycin cardiomyopathy and its modulation by probucol
D Kumar et al.
ANTIOXIDANTS & REDOX SIGNALING (2001)
Altered antioxidant defence in a mouse adriamycin model of glomerulosclerosis
A Deman et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2001)